New York trio and A&O on Novartis

Author: Nicholas Pettifer | Published: 8 Jan 2010

Wachtell Lipton Rosen & Katz and Allen & Overy are advising pharmaceutical company Novartis on its $28 billion...
Only subscribers to the full IFLR service have access to this article.  Please log in or subscribe now.

Alternatively, some articles are available if you take a free trial, giving you 7 days of free access to IFLR.
 

The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our terms and conditions and privacy policy before using the site. All material subject to strictly enforced copyright laws. © 2011 Euromoney Institutional Investor PLC. For help please see our FAQ.

Upcoming events

  • 22feb

    Asia M&A Forum

    Island Shangri-La Hotel, Hong Kong February February 22-23 2012

Web seminars

Proposed US offering reforms
March 8, 2012
4.00 pm GMT 

Supplements